Characteristics of breast cancer tumors in Lebanon: Where do we stand? No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This ...

A phase II study of capecitabine (CAP) plus PHY906 in patients (pts) with advanced pancreatic cancer (APC) No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...

Sentinel lymph node biopsy (SLNB) has become an indispensable procedure for staging various malignancies by identifying the first draining lymph node from a primary tumour. Traditional approaches have ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...

A Key Player in Cancer Diagnosis When someone receives a cancer diagnosis, one of the very first questions on every doctor’s mind is: has it stayed put, or has it begun to make its way through the ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...

Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...

The Melanoma Institute of Australia (MIA) previously developed a risk calculator for sentinel lymph node (SLN) metastasis risk to help clinicians and patients with primary cutaneous melanoma decide ...

Adoption of recommendations to skip sentinel lymph node biopsy (SLNB) in older women with hormone-receptor (HR)-positive, HER2-negative early-stage breast cancer may be slowly gaining traction in the ...

Please provide your email address to receive an email when new articles are posted on . Armando E. Giuliano, MD, will receive the 2025 William L. McGuire Memorial Lecture Award. Giuliano is being ...